Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 19.79 Billion | USD 44.74 Billion | 8.5% | 2024 |
FrequentlyAsked Questions
Cell-based assays help in determining the proficiency of compounds in a cellular environment.
The global cell-based assays market is expected to grow due to Rising drug discovery and toxicity testing needs fuel demand. Advancements in high-throughput screening and cell biology support market expansion.
According to a study, the global cell-based assays market size was worth around USD 19.79 Billion in 2024 and is expected to reach USD 44.74 Billion by 2034.
The global cell-based assays market is expected to grow at a CAGR of 8.5% during the forecast period.
North America is expected to dominate the cell-based assays market over the forecast period.
Leading players in the global cell-based assays market include F. Hoffmann-La Roche Ltd. (Roche Holdings AG), BD, Promega Corp., Bio-Rad Laboratories, Inc., Merck KGaA, Corning Inc., Charles River Laboratories, Lonza AG, Danaher Corp., and Thermo Fisher Scientific Inc., among others.
The report explores crucial aspects of the cell-based assays market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed